A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.
- Status
- COMPLETED
- Phase
- PHASE2
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE1
Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)
- Status
- TERMINATED
- Phase
- PHASE2
Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
GRN1005 for Brain Metastases From Breast or Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
- Status
- TERMINATED
- Phase
- PHASE3
Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib With Trastuzumab in Treating Patients With HER2-Negative/HER2 Mutant Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive
- Status
- COMPLETED
- Phase
- PHASE2